| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/28/2004 | CN1159064C Group A streptococcal polysaccharide immunogenic compositions and methods |
| 07/28/2004 | CN1159036C Eye drops |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767995 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/27/2004 | US6767741 Metal binding compounds and their use in cell culture medium compositions |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767713 Pasteurella neuraminidase diagnostic methods and immunoassay kit |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767546 Effective for providing significant weight gain compared to vaccination alone |
| 07/27/2004 | US6767542 Fusing to the antigen a non-hemolytic truncated form of listeriolysin o |
| 07/27/2004 | US6767541 HER-2/neu overexpression abrogates growth inhibitory pathways |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/24/2004 | CA2455701A1 The use of cross-protection to identify novel vaccine candidates for infectious agents |
| 07/24/2004 | CA2428744A1 Inhibition of lysozyme in treating sepsis-induced myocardial dysfunction |
| 07/22/2004 | WO2004061423A2 Compositions and methods for diagnosing and treating colon cancers |
| 07/22/2004 | WO2004061093A1 Immunizing fish against viral infection |
| 07/22/2004 | WO2004060915A2 Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. |
| 07/22/2004 | WO2004060911A2 Combination therapy with co-stimulatory factors |
| 07/22/2004 | WO2004060396A2 Immunogenic compositions containing phospholpid |
| 07/22/2004 | WO2004060386A1 Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein |
| 07/22/2004 | WO2004060381A1 Rabbit skin comprising biological active substance and its use |
| 07/22/2004 | WO2004060343A1 Antibody-containing particles and compositions |
| 07/22/2004 | WO2004060320A2 Methods of improving health-related quality of life in individuals with systemic lupus erythematosus |
| 07/22/2004 | WO2004060319A2 Immunostimulatory combinations |
| 07/22/2004 | WO2004060317A2 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004060295A2 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | WO2004060291A2 Uses of mammalian cytokine; related reagents |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060266A2 Eye-drop vaccine containing copolymer poly-ye for therapeutic immunization |
| 07/22/2004 | WO2004060265A2 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 07/22/2004 | WO2004060145A2 Isolation and identification of cross-reactive t cells |
| 07/22/2004 | WO2004060041A2 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | WO2004044000A3 Compounds and methods for modulating functions of classical cadherins |
| 07/22/2004 | WO2004032865A9 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 07/22/2004 | WO2004029617A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/22/2004 | WO2004027049B1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 07/22/2004 | WO2004026238A8 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004019974A3 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/22/2004 | WO2004019861A3 Stable ph optimized formulation of a modified antibody |
| 07/22/2004 | WO2004019860A3 Formulations of modified antibodies and methods of making the same |
| 07/22/2004 | WO2004014936A3 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 07/22/2004 | WO2004014418A3 Neisserial vaccine compositions comprising a combination of antigens |
| 07/22/2004 | WO2004014417A3 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 07/22/2004 | WO2004013279A9 Helix-hairpin-helix motifs to manipulate properties of dna processing enzymes |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004005325A3 Antigen-polymer compositions |
| 07/22/2004 | WO2003075849A3 Composition and method for enhancing immune response |
| 07/22/2004 | WO2003075843A3 Multiple and multivalent dna vaccines in ovo |
| 07/22/2004 | WO2003073916A3 Immune regulation |
| 07/22/2004 | WO2003059949A3 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/22/2004 | WO2003039470A3 Polyvalent immunogen of hiv |
| 07/22/2004 | WO2003028668A3 Gammaglobulin treatment of immune disorders |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2003017919A3 Composition comprising wenguanguo extracts, methods for preparing same and uses therof |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003012395A3 Early detection of mycobacterial disease using peptides |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | US20040143112 Immunomodulatory oligonucleotides |
| 07/22/2004 | US20040143103 Comprises nucleotide sequences coding mitogens for treating psoriasis, vision defects, tumors and arthritis |
| 07/22/2004 | US20040143101 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 07/22/2004 | US20040143099 for treatment or prevention of a thrombotic or coagulopathic disease, respiratory or inflammatory disease |
| 07/22/2004 | US20040142960 Yohimbine as immunobiologically active agent |
| 07/22/2004 | US20040142890 Methods and compositions for treating prostate cancer using DNA vaccines |
| 07/22/2004 | US20040142889 fusion polypeptide, comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell |
| 07/22/2004 | US20040142887 biodegradable polymeric delivery system such as glycolic acid-lactic acid copolymer; a biologically effective amount of an antigen; and a basic additive |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142872 Polyamine modified antibodies having specific binding affinity for A beta also have increased permeability at the blood-brain barrier and can be used for passive immunization and treatment of Altzheimer's disease |
| 07/22/2004 | US20040142871 Osteoporosis treatment |
| 07/22/2004 | US20040142863 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 07/22/2004 | US20040142475 Delivery systems for bioactive agents |
| 07/22/2004 | US20040142469 Nucleotide sequences comprising unmethylated cytosine and guaninedinucleotides for use as antisense tools in treatment and prevention of viral diseases; viricides |
| 07/22/2004 | US20040142468 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules |
| 07/22/2004 | US20040142464 Transgenic human cells expressing superantigens/antiproliferative agents for use as gene therapeutic tools in cancer treatment ; tissue engineering |
| 07/22/2004 | US20040142455 Recombinant botulinum toxins having a soluble C-terminal portion of a heavy chain, an N-terminal portion of a heavy chain and a light chain |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142450 Swine respiratory system tissues for use as bioreactors for preparing influenzal viral particles for use in identification of viricides; tissue engineering and vaccine development |
| 07/22/2004 | US20040142449 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells |
| 07/22/2004 | US20040142448 Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142394 Method for diagnosing a tumor in a patient determining the concentration of PIBF |
| 07/22/2004 | US20040142388 Method for detecting chronic dementia diseases, and corresponding VGF peptides and detection reagents |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040142361 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142342 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions |
| 07/22/2004 | US20040142332 Desaturase antigen of mycobacterium tuberculosis |
| 07/22/2004 | US20040142004 Avian pneumovirus vaccine |
| 07/22/2004 | US20040142003 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 07/22/2004 | US20040141998 antigen is targeted to the receptor of the antigen-presenting cell, in some instances without being blocked by the natural ligand for the surface receptor; molecular complexes including the binding agent coupled to an antigen. |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141995 MHC class I-restricted and MHC class II-restricted EBNA1 peptides |
| 07/22/2004 | US20040141992 derived from the same antigen as the substance eliciting the allergic reaction; contains an epitope different from that evoking the allergic reaction, yet does not elicit the allergic reaction |
| 07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 07/22/2004 | US20040141990 Metastic colorectal cancer vaccine |